John P. Sharp - 19 Nov 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
Chief Financial Officer
Signature
/s/ John P. Sharp
Issuer symbol
N/A
Transactions as of
19 Nov 2021
Net transactions value
+$4,054
Form type
4
Filing time
23 Nov 2021, 17:53:20 UTC
Previous filing
03 Nov 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $4,054 +2,017 +3.5% $2.01* 59,741 19 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).